CHARLES SCHWAB INVESTMENT MANAGEMENT INC - AVROBIO INC ownership

AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 66 filers reported holding AVROBIO INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of AVROBIO INC
ValueSharesWeighting
Q4 2022$26,542
+10.6%
37,2310.0%0.00%
Q3 2022$24,000
-31.4%
37,2310.0%0.00%
Q2 2022$35,000
-68.8%
37,231
-55.7%
0.00%
Q1 2022$112,000
-70.2%
84,117
-13.7%
0.00%
Q4 2021$376,000
-26.7%
97,485
+6.1%
0.00%
Q3 2021$513,000
-76.8%
91,882
-63.0%
0.00%
-100.0%
Q2 2021$2,209,000
-21.0%
248,394
+12.7%
0.00%0.0%
Q1 2021$2,797,000
-9.2%
220,346
-0.3%
0.00%0.0%
Q4 2020$3,081,000
+17.8%
220,962
+10.0%
0.00%0.0%
Q3 2020$2,616,000
-17.5%
200,868
+10.6%
0.00%
-50.0%
Q2 2020$3,170,000
+34.6%
181,654
+20.0%
0.00%
+100.0%
Q1 2020$2,356,000
-11.1%
151,402
+15.1%
0.00%0.0%
Q4 2019$2,649,000
+43.1%
131,557
+0.4%
0.00%0.0%
Q3 2019$1,851,000
+99.2%
131,080
+129.4%
0.00%0.0%
Q2 2019$929,000
-4.8%
57,134
+29.1%
0.00%0.0%
Q1 2019$976,000
+78.8%
44,253
+35.1%
0.00%
Q4 2018$546,000
-68.5%
32,767
-2.0%
0.00%
-100.0%
Q3 2018$1,735,00033,4340.00%
Other shareholders
AVROBIO INC shareholders Q2 2019
NameSharesValueWeighting ↓
Atlas Venture Life Science Advisors, LLC 4,520,863$5,968,0000.76%
Aisling Capital Management LP 1,009,779$1,333,0000.72%
MPM BioImpact LLC 647,918$855,0000.23%
GMT CAPITAL CORP 2,594,914$3,425,0000.22%
New Leaf Venture Partners, L.L.C. 315,550$417,0000.21%
GSA CAPITAL PARTNERS LLP 338,422$447,0000.06%
Penn Mutual Asset Management, LLC 37,306$49,0000.06%
Eversept Partners, LP 295,369$389,8870.03%
XTX Topco Ltd 23,289$31,0000.01%
Colonial River Wealth Management, LLC 17,636$23,0000.01%
View complete list of AVROBIO INC shareholders